Language selection

Search

Patent 2229666 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2229666
(54) English Title: SPRAY APPLICATOR
(54) French Title: APPLICATEUR D'AEROSOL
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61M 15/00 (2006.01)
  • A61M 15/08 (2006.01)
(72) Inventors :
  • OPPERMAN, NICHOLAS RICHARD JAMES (United Kingdom)
(73) Owners :
  • PHARMASOL LIMITED
  • PHARMASOL LIMITED
(71) Applicants :
  • PHARMASOL LIMITED (United Kingdom)
  • PHARMASOL LIMITED (United Kingdom)
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 1996-08-16
(87) Open to Public Inspection: 1997-02-27
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/GB1996/002011
(87) International Publication Number: WO 1997006842
(85) National Entry: 1998-02-17

(30) Application Priority Data:
Application No. Country/Territory Date
9516984.3 (United Kingdom) 1995-08-18
9604759.2 (United Kingdom) 1996-03-06

Abstracts

English Abstract


A multi-dose spray applicator is disclosed for dispensing a pharmaceutical
from a sealed container, said applicator comprising means for holding the
container, a manually operable metering pump for delivering said
pharmaceutical as a nasal spray and a hollow needle associated with said pump
for penetrating a membrane sealing said container and dispensing the
pharmaceutical through the pump, said container having a movable wall or plug
which is movable to displace liquid from the container as it is dispensed by
the pump.


French Abstract

Cet applicateur d'aérosol multi-dose permet de délivrer un produit pharmaceutique contenu dans un récipient fermé et comprend un dispositif renfermant ce récipient, une pompe manuelle de dosage, qui libère ce produit pharmaceutique sous forme d'aérosol nasal, et une aiguille creuse associée à la pompe pour pénétrer dans une membrane fermant le récipient et délivrer le produit pharmaceutique par la pompe. Ce récipient comporte une cloison ou un bouchon mobile qui se déplace pour expulser le liquide du récipient lorsqu'il est délivré par la pompe.

Claims

Note: Claims are shown in the official language in which they were submitted.


- 11 -
CLAIMS
1. A multi-dose spray applicator for dispensing a pharmaceutical from a
sealed container, said applicator comprising means for holding the container, a
manually operable metering pump for delivering said pharmaceutical as a nasal
spray and a hollow needle associated with said pump for penetrating a membrane
sealing said container and dispensing the pharmaceutical through the pump,
characterised in that said container has a movable wall or plug which is movableto displace liquid from the container as it is dispensed by the pump.
2. An applicator as claimed in claim 1, which includes means for moving the
needle towards the membrane on initial actuation of the pump.
3. An applicator as claimed in claim 2 which includes a removable device to
prevent the needle penetrating the membrane until the applicator is intended to
be used.
4. An applicator as claimed in claim 3 in which the safety device comprises
a shield located between the membrane and the needle, said shield being movable
to an inoperative position when the applicator is intended to be used.
5. An applicator as claimed in claim 3 in which the safety device comprises
a locking means which in its operative position prevents a component carrying
the pump from moving towards the container to an extent that the needle
penetrates the membrane.
6. An applicator as claimed in any one of the preceding claims wherein the
plug is movable into the container under the influence of a spring.

12
7. An applicator as claimed in any one of the preceding claims in
which the pump is primed by movement of the needle into the container.
8. An applicator as claimed in any one of the preceding claims
wherein the means for holding the container comprises a housing said housing
comprising a base part for holding said container and a top part for holding thepump, the top and base parts being relatively movable to allow the needle to
penetrate the membrane.
9. An applicator as claimed in claim 8 wherein the base part is
slidable within the top part and the two parts include co-operating means for
holding them together with the end of the needle within the container and the
membrane forming a seal around the needle.
10. An applicator as claimed in claim 9 wherein the co-operating
means include at least one resilient finger on one part which is engageable in arecess in the other part.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02229666 1998-02-17
-- 1 --
SPRAY ~PPLICATOR
This invention relates tO spray applicators, particularly for dispensing
pharm~ce~ltical substances. One established method of dispensing
5 pharm~ce~ltir~lc is by spray e.g as a nasal or oral spray. This method has theadvantage as compared with sub-cutaneous or i~ dvellal injection that it is easier
for a patient with poor co-ordination or mllscul~r weakness to ~mini~ter the
pharmaceutical himcelf In the past, containers fitted with a pump or aerosol
packaged products have been employed. However, these methods have proved
10 to be lln~ti~f~ory for pa~k~ging pharmaceuticals which are sensitive to
substances in the atmosphere, such as compounds which degrade by contact with
water or oxygen.
It is, therefore, one object of the present invention to provide an applicator for
15 dispensing pharm lreuticals in the form of a spray, which minimices contact with
atmospheric components until the product is dispensed.
WO 95/00195 discloses a spray applicator for dispensing a pharmaceutical from
a sealed container, said applicator comprising means for holding said sealed
2 o container, a manually operable pump for delivering said pharm~relltic~l as a nasal
spray and a hollow needle associated with said pump for penetrating a membrane
sealing the container and dispensing ~he pharm~re~ltical through the pump. In
accordance with the present invention, such a spray applicator is characterised in
that the container has a moveable wall or plug which is movable to displace
2 5 liquid from the container as it is dispensed by the pump. An advantage of the
invention is that liquid from within t:he container can be displaced without theneed to introduce air or other gas into the sealed container.
The applicator of the present invention is particularly designed for dispensing
3 o pharm~rellticals which are sensitive to oxygen or water. One example of sucha compound is apomorphine hydrochloride (or other pharm~reutically acceptable
salt) which is widely used in the tre~t'n~?nt of Parkinson's disease. For such use,
) S~E~

CA 02229666 1998-02-17
apomorphine is conveniently applied as a nasal spray and is rapidly absorbed
through the nasal membrane. The spray applicator may, however, be adapted
for other purposes, e.g. for applying a spray to the mouth and for dispensing
other pharma~ellti~lc via the mouth or nose, particularly for treating the mouth,
5 nose and lungs.
The pump component of the applicator may be constructed as a metering pump
so that on actuation of the pump, a metered dose of the pharmacelltical is
sprayed into the patient's nose or mouth.
Preferably, the applicator includes means for moving the needle towards the
membrane automatically on actuation or just prior to actuation of the pump.
For example, depression of the pump system may cause the needle to move
towards and penetrate a membrane sealing the container in which the
15 pharmaceutical is packaged.
In order to prevent the device from being act~l~ted lmintPntionally, the applicator
may include a removable device such as a clip, ring or tag which prevents the
needle penetrating the membrane or prevents, respectively, means carrying the
2 o needle and sealed container from coming together until the applicator is intended
to be used.
When the needle penetrates the membrane over the end of the vial, the contents
remain subst2ntially sealed with respect to the atmosphere so that air cannot
2 5 enter the vial.
The moveable wall or plug may be urged inwardly by a spring or other
m~hani~
)~~)

CA 02229666 1998-02-17
W O 97/06842 PCT/GB96/02011
device so as to assist priming the pump although the spring is not essPnti~l
The co~tainer may be constructed as a collapsible container~ such as a tube, by
making the walls fiom a ~e~ible material snch as a plastics sheet material.
One ph~tm~celltic~l application of ~he spray applicator is for di~e~ g
compounds for controlling Parkinson's Disease. Patients suffering from
Parkinson's Disease often have difflculty in manipulating devices for
~l,n;";~l~,~g their me~ tic)n. A further feature of the applicator of the
in~ention is to provide a dispensin_ cap in which the outlet from the pump is
angled obliquely, thus providing a platform on the cap of the applicator which
enables the patient to operate the pump collveniently with his thumb.
Two embotlim~nt~ of the present i~vention will now be desc;ibed with
reference to the acco~a~ying drawings, which are partly s~hem~tic.
In the acco~ ing drawings:-
Figure 1 is a longih~ n~l section through the applicator in ~cs~mhle(lcondition,Figure 2 is a perspective view of a clip for preventing the needle
penetrating the sealed container,
Figure 3 shows the components of the applicator in a ~lic~cseml-led
state~
Figure 4 is a schem~tic view showing an ~lt~t~tive _ethod of actuating
the pump,
Figure 5 is a longit~l~in~l view in section of a second embodiment of the
applicator in its "use" position;
Figure 6 is a similar section through the applicator shown in Figure 5
but in its "rest" position:

CA 02229666 1998-02-17
WO 97/06842 PCT/GB96/02011
Figures 7 shows the disassembled components of the applicator shown t
in Figures S and 6: and
Figures 8A and 8B are two perspective views of a modified dispenser.
Refer~ing to Figures 1 to 4 of the accolllp~ying drawings, the nasal
applicator coll.plises a container (I) shaped to receive a sealed vial (2) into
which the ph~rm~ceutical is packaged. Vial (2) is of a type which is ~;u~ ly
used in the phann~r,elltir-~l industrv for F~ck~in~ injectable m~tPn~lc. The
vial com~lises a glass or plastics tube (3) having a lower end which is closed
with a rubber or plastic bung or plug (4). The upper end of the vial has
,.,~."~l~e (S) which is decign~cl to be penetrated by a hypodermic needle for
remov~ng the col,lellLs. After penetration of the ,..~ ue the m~l~e is
snffir,iPn~ly elastic to close around the needle and seal itself against inadvertent
escape of iiquid or escape under the p,es~ arising during pumping of doses
of liquid from Ihe container. The ~ blaile is preferably a rubber or rubbery
plastics m~tPri~l Vial (2) is desis~nP~l to be a multi-dose container so that asliquid is removed from the vial (2), plug (4) moves upwardly to displace the
li~uid so removed. A spring (6) may be ernployed to assist this action and/or
priming of the pump but is not ess~nti~l At its upper end, co.~l~e~ (1) is
threaded to receive a cap (7) and a pump holder (8) is mounted for a~ial slidingmovement on the neck (9) of the container (1). Crimped onto the nec3~ (10)
of the pump holder (8) is a pump (11) and mounted on the upper end of the
pump is a nasal actuator and overcap (12) and (13) respectively. Pump (l l) is
of the kind conventionally used for pumping ph~rm~ceuticals from closed
containers. ~he pump may be an ~ùrless mech~ni~l pump with or without a
dosing device such as those m~nllf~ctured by Perfect-Valois or their parent

CA 02229666 1998-02-17
W O 97/06842 PCT/GB96/02011
company Valois Step under model No. ''VP 7'. An e,Yample of a metermg
pump of this kind is also described in WO 95/09054.
The lower end of the pump (11) has a tubular portion (14) to which a
hollow needle (15) is ~tt~r,hlod either int~m~lly or .o-~tPrn~lly, e.g. by means of a
luer-type connection.
The applicator works in the following manner. Cap (13) which is a
press fit of actuator (12) is removed and lhe actuator pressed down bv placing
the fingers on ledges (16). This causes pump holder (8) to move downwardly
until needle ~15) penetrates the membrane (5) and enters the liquid contained in~ial (''). Co.~ "~g downward L~l~s~ causes the pump to take in a dose of
the pharmaceutical and to spray the dose through the nasal actuator (12!. On
release of such finger pressure. nee-dle (1~) remains in the vial with the
m~ml,l~e sealing ~round the needle to prevent escape of liquid between the
outer surface of the needle and the L~ e. This is because the lm~ltqrsirle 26
of the cap engages ~,~th the recess ' ~ of the cap 8 or the annular projection 27
engages in the groove 21. The piston (not sho~.~) within pump 11 is returned
to its initiai position by a return spring within the pump housing 11. This
aspirates liquid into the pump ready for dispensing the next dose from the vial.Fu~ther doses of liquid can be ~ Jed from the vial by the patient as required
by pressing on the ledges 16.
In order to prevent the applicator from being inadvertently act~te~l, a
removable clip (20) may be fitted into a groove (21) in the neck (9) of
container (1). The clip (20) may be m~mlf~ red from a springy plastics
material so that it is readily removed by pulling the tag or ring which is ~tta~llefl
to it. When the clip (20) is in place~ however, its thiclcness or an abutment

CA 02229666 1998-02-17
WO 97/06842 PCT/GB96/02011
protruding from it, prevents the pump holder moving down the neck (9)
~u~. ;~ .1 ly far to allow the hollow needle to penetrate the ~ ;~e (~
Figure 4 shows an ~ltern~tive way of depressing the actuator (1~) for
patients who have very poor co-ordination or muscular power. In this
mo-lifi~tion, the container (1) mav be gripped by a holder (30) having a lever
(31) mounted thereon. Lever (31) has an arm (32) which is shaped to press
onto shoulders (16) of the nasal actuator (1~). By operating lever arm (33)~
the patient is able to actuate the applicator with 111;11;11111111 mech~ni~l force.
It wilI be appreciated that various modifications can be rnade to the
applicator in accordance with the invention. For example, the holder may be
formed u~th a threaded~ removable base for introducing the vial and the nec~
(7) may be formed integra;ly with the body (1). The pllmr unit may be cnmped
dùwllw~lly onto the neck of the holder and be arranged to be movable
do~,vnwardly to permit the needle to enter the membrane (5).
Conveniently, most of the components of the applicator may be
m~mlf~ctllred from plastic materials. The holder (1) may, for e~ample, be
made from a clear plastics material so that the patient call see whether the vial
is empty. In the case of apomorphine, the ph~ celltir~l turns green after
exposure to atmospheric oxygen. Once the cu~ s of the vial are observed
to have changed to a green colour which is sllffici~ntlv deep (as intli~ted by ashade chart on the applicator or pack~ing), to indicate that the pharmace~tic~l
is no longer effective. An important aspect of the application of this invention is
that the pharmaceutical in the vial remains sealed from the atmosphere until thepatient uses the applicator for the first time.

CA 02229666 1998-02-17
W O 97/06842 PCT/G B96/02011
Figures 5! 6, 7, 8A & 8B show ~modified applicators which include a
"~hel of mo~ifi~ti~ns but work in a similar fashion to the applicator shown
in Figures l to 4.
Refernng to Figures 5, 6 and 7, the modified dispenser comprises an
outer hollow component (101) forming one part of a container. preferably
moulded from plastics m~tPri~l In the embodiment shown in these Figures, the
pump (105) is the same kind of metering pump as already described in
connection with Figures 1 to 4. Also, the vial ( 1 1 1 ) is ~csPnti~lly as described
in relation to the embo~l;,-.r~ of Figures l to 4. The differences concern the
container for the vial and the nozzle through v.~hich the product is dispensed.
Component (101) is open at one end (l02) and at its other end (103) is formed
with a mouth and throat (104) for leceivillg a dosing pump (105). Pump (105)
is preferably crimped into the mouth (104) of component (101). e.g. with an
",;,.;~..., closure ferrule. A hollow needle (106) is fitted to the pump (105).
A second co~ollent (107) of the container is slidably received in the
tubular hollow part of co~ u.~ent (101) Again~ the second component is
conveniently moulded fromplastics material. Component (107) is formed ~,vith
two longim~lin~lly spaced grooves (108) and (109) and the inside of the
coll.pollent (101) is formed with a cu-,~ollding annular ring or projection
(1 10).
Component (107) is formed with a tubular cavity for receiving a vial
(111) and has a closed base (112) and a neck (1 13). Vial (111) is retained
within the component (107) by a Lhreaded cap (114) which engages with
corresponding threads on the inside of the neck of the component (107).
~lt~rn~tively, the cap (114) may be a friction fit in the neck of component

CA 02229666 1998-02-17
W O 97/06842 PCT/GB96/02011
(107) or one of the components may have lug(s) which enga~e with groove(s)
or lecesses. In use, the shoulder of the vial (111) will abut against the cap
(114) or the neck will abut against a ledge (115). However. for clarity a slightgap is shown in the drawing. Vial (111) is a tube open at its lower end but
incl~ld~s a sealing plug (116) (preferably of elastomeric material). Plug (116)
is preferably in contact with a spring ( 117) tending to urge the plug towards the
neck of the vial.
As shown in Fi~ure 6~ the cap (114) is formed with a slot (118) into
which a guard strip (1 19) slides. Guard strip (1 19) passes through slots (118A& I 1 8B) in components ( 101 & 107) which are aligned with slots ( 1 18) in cap(114). The width and to~l~hness of strip (119) is such that it would be dif~icult
for needle (106) to penetrate it and reach the ~ ue across the neck of vial
(111).
Pump (105) has an outlet tube (120) depression of which causes the
pump to operate. Tube (1'0) is received within a nasal spray head (121)
which has a dispensing nozzle (12 ) connected to the tube (120). Nozzle
(12 ') e~ctends obliquely to the cerltre line of the dispenser so as to provide a
convenient ledge (123) for the patient to apply finger p-es~u,e to operate the
device.
The dispenser shown in Figures 5, 6 and 7 works in the following
manner. In the position shown in Figure 6, the projection (110) engages in
groove ( 108) and releasably retains the inner component in relation to the outer
co~ ol-ent (101) in the position shown in Figure 6.
When it is desired to use the dispenser~ the guard strip (119) is pulled
out by pulling on the ring (120). The dispenser c~ then be operated by

CA 02229666 1998-02-17
WO 97/0684Z PCT/GB96/02011
pressing the base (112) on a flat surface and pressing, e.g. with the thumb on
the ledge (123). This causes the inner component to be pressed into the outer
component (101) and the needle to penetrate the membrane (174) across the
neck ofthe vial. At the same time. the almular projection (110) engages in the
groove (109) thus ret~ining the compone~t (107) within the component (101).
For this purpose, projection (110) can be made to be a better fit in groove
(109) than in groove (108) so that it is easier to dislodge projection (110) from
~roove (108) than groove (109).
It has been found that a needle which has a very slight or no taper at all
is best employed. This is because needles with a long taper tend to allow the
contents of the vial to spray out as the needle begins to penetrate the
~e~ LLe. However. co~lvellLiOnalneedles maybe employed.
The walls of the components (101,107) may be transparent or include a
~,vindow. This arrangement enables the contents of the vial to be cherk~d, e.g.
to see if the vial contains s~ffici~nt liquid ~or one more L~r~ l or, in the case
of some mP~lic~l.-r--lc~ to check the a~e~ce of the co~-Le~ since this can
undergo a colour change which mav in-lir~te it is no longer effective.
Instead of having a spring such as the spring (6) shown in the
embo-limPnt~ of Figures l to 3, a projection is moulded on the base (108).
This projection bears on the plug (112) so that when the applicator is i~itiallyactivated, the plug is urged upwardlv and primes the pump.
Figures 8A and 8B show ~xt~.rrl~l perspective views of a modified
dispenser. In this embodiment. the vial (not visible) is contained within a body400 which may be formed from iuneI and outer components similar to
components ( 101,107) in Figures ~ and 6. A guard strip (401 ) is received in a

CA 02229666 1998-02-17
WO 97/06842 PCT/GB96/02011
slot (402) and prevents the dispenser bein_ actuated inadvertently. A spray
head (403) is fitted to the diachal~e tube of the pump and provides a platform
(404) for applying finger or thumb ~lcaaulc to operate the pump. ~ozzle
(405) terminates in a discharge outlet which may incorporate various outlet
designs to vary the spray pattern. A closure cap (405) rnay be fitted over the
nozzle to protect the nozle for storage and Lldlla~OI ~.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC expired 2023-01-01
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Application Not Reinstated by Deadline 2001-08-16
Time Limit for Reversal Expired 2001-08-16
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2000-08-16
Inactive: Single transfer 1998-05-25
Inactive: IPC assigned 1998-05-20
Classification Modified 1998-05-20
Inactive: First IPC assigned 1998-05-20
Inactive: Courtesy letter - Evidence 1998-05-12
Inactive: Notice - National entry - No RFE 1998-05-08
Application Received - PCT 1998-05-05
Application Published (Open to Public Inspection) 1997-02-27

Abandonment History

Abandonment Date Reason Reinstatement Date
2000-08-16

Maintenance Fee

The last payment was received on 1999-08-05

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Basic national fee - standard 1998-02-17
Registration of a document 1998-02-17
MF (application, 2nd anniv.) - standard 02 1998-08-17 1998-02-17
MF (application, 3rd anniv.) - standard 03 1999-08-16 1999-08-05
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
PHARMASOL LIMITED
PHARMASOL LIMITED
Past Owners on Record
NICHOLAS RICHARD JAMES OPPERMAN
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 1998-02-16 2 58
Abstract 1998-02-16 1 47
Description 1998-02-16 10 372
Drawings 1998-02-16 7 99
Representative drawing 1998-05-25 1 6
Notice of National Entry 1998-05-07 1 193
Courtesy - Certificate of registration (related document(s)) 1998-08-11 1 140
Courtesy - Abandonment Letter (Maintenance Fee) 2000-09-12 1 184
PCT 1998-02-16 18 645
Correspondence 1998-05-11 1 28
Fees 1999-08-04 1 50